Padró T - Search Results

1

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia.

Mesters RM, Padró T, Bieker R, Steins M, Kreuter M, Göner M, Kelsey S, Scigalla P, Fiedler W, Büchner T, Berdel WE. Mesters RM, et al. Among authors: padro t. Blood. 2001 Jul 1;98(1):241-3. doi: 10.1182/blood.v98.1.241. Blood. 2001. PMID: 11418488 Free article.

2

Efficacy and safety of thalidomide in patients with acute myeloid leukemia.

Steins MB, Padró T, Bieker R, Ruiz S, Kropff M, Kienast J, Kessler T, Buechner T, Berdel WE, Mesters RM. Steins MB, et al. Among authors: padro t. Blood. 2002 Feb 1;99(3):834-9. doi: 10.1182/blood.v99.3.834. Blood. 2002. PMID: 11806984 Free article. Clinical Trial.

3

Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.

Bieker R, Padró T, Kramer J, Steins M, Kessler T, Retzlaff S, Herrera F, Kienast J, Berdel WE, Mesters RM. Bieker R, et al. Among authors: padro t. Cancer Res. 2003 Nov 1;63(21):7241-6. Cancer Res. 2003. PMID: 14612519

4

Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.

Schliemann C, Bieker R, Padro T, Kessler T, Hintelmann H, Buchner T, Berdel WE, Mesters RM. Schliemann C, et al. Among authors: padro t. Haematologica. 2006 Sep;91(9):1203-11. Haematologica. 2006. PMID: 16956819

5

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Dankbar B, Padró T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J. Dankbar B, et al. Among authors: padro t. Blood. 2000 Apr 15;95(8):2630-6. Blood. 2000. PMID: 10753844 Free article.

6

Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.

Padró T, Ruiz S, Bieker R, Bürger H, Steins M, Kienast J, Büchner T, Berdel WE, Mesters RM. Padró T, et al. Blood. 2000 Apr 15;95(8):2637-44. Blood. 2000. PMID: 10753845 Free article.

7

[Angiogenesis in patients with hematologic malignancies].

Mesters RM, Padró T, Steins M, Bieker R, Retzlaff S, Kessler T, Kienast J, Berdel WE. Mesters RM, et al. Among authors: padro t. Onkologie. 2001 Sep;24 Suppl 5:75-80. doi: 10.1159/000055192. Onkologie. 2001. PMID: 11600818 Review. German.

8

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.

Padró T, Bieker R, Ruiz S, Steins M, Retzlaff S, Bürger H, Büchner T, Kessler T, Herrera F, Kienast J, Müller-Tidow C, Serve H, Berdel WE, Mesters RM. Padró T, et al. Leukemia. 2002 Jul;16(7):1302-10. doi: 10.1038/sj.leu.2402534. Leukemia. 2002. PMID: 12094254 Clinical Trial.

9

Thalidomide for the treatment of acute myeloid leukemia.

Steins MB, Bieker R, Padró T, Kessler T, Kienast J, Berdel WE, Mesters RM. Steins MB, et al. Among authors: padro t. Leuk Lymphoma. 2003 Sep;44(9):1489-93. doi: 10.3109/10428190309178769. Leuk Lymphoma. 2003. PMID: 14565649 Review.

10

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.

Bisping G, Leo R, Wenning D, Dankbar B, Padró T, Kropff M, Scheffold C, Kröger M, Mesters RM, Berdel WE, Kienast J. Bisping G, et al. Among authors: padro t. Blood. 2003 Apr 1;101(7):2775-83. doi: 10.1182/blood-2002-09-2907. Epub 2002 Nov 27. Blood. 2003. PMID: 12517814 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters